Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-18
2007-09-18
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S383000, C548S255000, C548S262200
Reexamination Certificate
active
10503469
ABSTRACT:
A method for producing an optically active 2-phenyl-2,3,-dihydroxypropyl azole derivative, which is a useful compound in various fields. An optically active α-hydroxycarboxylic acid derivative represented by general formula (1) is used as a starting material and is allowed to react with an azole acetic acid derivative (2) to produce a new, optically active azole-alkyl ketone derivative (3). Subsequently, a new, optically active azole-methyl alcohol derivative (5) is produced by highly diastereoselective alkylation by an appropriate combination of a protective group and an organometallic reagent (4). Furthermore, the optically active azole-methyl alcohol derivative (5) is selectively deprotected to produce an optically active 2-phenyl-2,3-dihydroxypropyl azole derivative (6)
REFERENCES:
patent: 5004494 (1991-04-01), Sugavanam et al.
patent: 5204363 (1993-04-01), Sugavanam et al.
patent: 5648372 (1997-07-01), Naito et al.
patent: 6300522 (2001-10-01), Crosby et al.
patent: 7060657 (2006-06-01), Hacker et al.
patent: 753513 (1997-01-01), None
patent: 97/31903 (1997-09-01), None
Patani et al., “Bioisosterism: A Rational Approach in Drug Design,” Chem. Rev. , 1996, 96, 3147-3176, especially p. 3157, Table 22.
Bartroli et al., “New Azole Antifungals. 3. Synthesis and Antifungal Activity of 3-Substituted-4(3H-quinazoliones1,2,”J. Med. Chem., 1998, pp. 1869-1882, vol. 41, No. 11, American Chemical Society*.
Tasaka et al., “Optically Activity Antifungal Azoles. I. Synthesis and Antifungal Activity of (2R,3R)-2-(2,4-Difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-butanol and Its Stereoisomers,”Chem. Pharm. Bull., Jun. 1993, pp. 1035-1042, vol. 41, No. 6*.
Girijavallabhan et al., “Synthesis of the Antifungal Agent SCH 424271(SM 9164),”Bioorganic&Medicinal Chemistry Letters, 1991, pp. 349-352, vol. 1, No. 7, Pergamon Press plc, Great Britain*.
Adam et al., “Synthesis of Optically Active α-Hydroxycarbonyl Compounds by (Salen)Mn(III)-Catalyzed Oxidation of Silyl Enol Ethers and Silyl Ketene Acetals,”Tetrahedron Letters, 1996, pp. 6531-6534, vol. 37, No. 36, Elsevier Science Ltd., Great Britain*.
“New Antifungal Agents,”Iyaku Journal, 2001, pp. 115-119 (2105-2109), vol. 37, No. 7 (English abstract).
Suzuki Tsuneji
Tsunoda Hidetoshi
Anderson Rebecca
Chung Susannah
Mitsui Chemicals Inc.
LandOfFree
Optically active azole derivative and process for producing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active azole derivative and process for producing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active azole derivative and process for producing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3801743